Hasil Pencarian - Jeffrey Weber

Perbaiki Hasil
  1. 1
    Response to: Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054 by Eggermont et al

    Response to: Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054 by Eggermont et al oleh James Larkin, Jeffrey Weber, Paolo Antonio Ascierto, Mario Mandala

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Accuracy of a Single Tunnel Technique for Reconstruction of the Interosseous Talocalcaneal Ligament

    Accuracy of a Single Tunnel Technique for Reconstruction of the Interosseous Talocalcaneal Ligament oleh Patrick Bull DO, Jeffrey Weber DPM, Eric So DPM

    Diterbitkan 2018-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastroesophageal malignancies undergoing systemic anti-cancer therapy.

    A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastro... oleh Scott Mitchell, John P Williams, Harsimrandeep Bhatti, Toufic Kachaamy, Jeffrey Weber, Glen J Weiss

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Structures at Risk with Plantar Approach Retrograde First Metatarsal Charcot Beam Screw Insertion

    Structures at Risk with Plantar Approach Retrograde First Metatarsal Charcot Beam Screw Insertion oleh David Larson DPM, Christopher Reb DO, Christopher Hyer DPM, Patrick Bull DO, Jeffrey Weber DPM

    Diterbitkan 2017-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.

    Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma. oleh Rebecca J Critchley-Thorne, Ning Yan, Serban Nacu, Jeffrey Weber, Susan P Holmes, Peter P Lee

    Diterbitkan 2007-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Preexisting immune‐mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitors

    Preexisting immune‐mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitors oleh Nicholas Gulati, Arda Celen, Paul Johannet, Janice M. Mehnert, Jeffrey Weber, Michelle Krogsgaard, Iman Osman, Judy Zhong

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    658 Toxicities of single agent and combination immune checkpoint inhibitors in patients with pre-existing autoimmune diseases

    658 Toxicities of single agent and combination immune checkpoint inhibitors in patients with pre-existing autoimmune diseases oleh Jeffrey Weber, Michelle Krogsgaard, Anna Pavlick, Mehmet Altan, Sabina Sandigursky, Safa Houssein, Xerxes Pundole, Elizaveta Efuni, Samuel Cytryn

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients

    The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients oleh Douglas Donnelly, Shirin Bajaj, Jaehong Yu, Miles Hsu, Arjun Balar, Anna Pavlick, Jeffrey Weber, Iman Osman, Judy Zhong

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    A genome-wide association study of germline variation and melanoma prognosis

    A genome-wide association study of germline variation and melanoma prognosis oleh Vylyny Chat, Vylyny Chat, Vylyny Chat, Sasha Dagayev, Sasha Dagayev, Sasha Dagayev, Una Moran, Una Moran, Matija Snuderl, Jeffrey Weber, Jeffrey Weber, Robert Ferguson, Robert Ferguson, Robert Ferguson, Iman Osman, Iman Osman, Iman Osman, Tomas Kirchhoff, Tomas Kirchhoff, Tomas Kirchhoff

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy.

    Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy. oleh Jessica Ann Chacon, Richard C Wu, Pariya Sukhumalchandra, Jeffrey J Molldrem, Amod Sarnaik, Shari Pilon-Thomas, Jeffrey Weber, Patrick Hwu, Laszlo Radvanyi

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Tumor immunogenomic signatures improve a prognostic model of melanoma survival

    Tumor immunogenomic signatures improve a prognostic model of melanoma survival oleh Leah Morales, Danny Simpson, Robert Ferguson, John Cadley, Eduardo Esteva, Kelsey Monson, Vylyny Chat, Carlos Martinez, Jeffrey Weber, Iman Osman, Tomas Kirchhoff

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    308 Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for melanoma

    308 Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for melanoma oleh Dirk Schadendorf, Mark Middleton, Jeffrey Weber, Delphine Hennicken, Paolo Ascierto, Andriy Moshyk, Roberto Zoffoli, Anne Pieters, Adenike Amadi, Katrin Kupas, Srividya Kotapati

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Intramedullary Screw Fixation and Relevant Diameter of the Proximal Phalanges of the Foot

    Intramedullary Screw Fixation and Relevant Diameter of the Proximal Phalanges of the Foot oleh Roberto Brandao DPM, Bryan Van Dyke DO, Benjamin Watson DO, Jeffrey Weber DPM, David Larson DPM, Maria McGann DO, Christopher Hyer DPM

    Diterbitkan 2018-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    390 A global, molecular disease characterization initiative (MDCI) in oncology clinical trials

    390 A global, molecular disease characterization initiative (MDCI) in oncology clinical trials oleh Jeffrey Weber, Hassane Zarour, David Carbone, Marcus Butler, Roma Patel, Melissa Johnson, Adrian Sacher, Edward Garon, Arindam Dhar, Cristina Messina, Kristin Blouch, Axel Hoos, Anne-Marie Martin

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    681 Single pipeline re-analysis revises microbiome associations with anti-tumor response to checkpoint inhibitors

    681 Single pipeline re-analysis revises microbiome associations with anti-tumor response to checkpoint inhibitors oleh James White, Jarushka Naidoo, Jeffrey Weber, Evan Lipson, Cynthia Sears, Bertrand Routy, Fyza Shaikh, Joell Gills, Taiki Hakozaki, Richard Corentin, Yusuke Okuma, Mykhaylo Usyk, Abhishek Pandey, Jiyoung Ahn

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology

    Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology oleh Laura C Cappelli, Maria E Suarez-Almazor, Michelle Turner, Stephane Champiat, Caroline Robert, Julie R Brahmer, Jarushka Naidoo, Jeffrey Weber, Joanne Riemer, Elad Sharon, Michael B Atkins, M Catherine Pietanza, Karthik Suresh, Catherine Murphy, Javid Moslehi, David Feltquate, Lee M Krug

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    776 Long-term efficacy and safety of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: a 4-year analysis of the C-144–01 study

    776 Long-term efficacy and safety of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: a 4-year analysis of the C-144–01 study oleh James Larkin, Harriet Kluger, Omid Hamid, Jeffrey Weber, Amod A Sarnaik, Brian Gastman, Jeffrey Chou, John M Kirkwood, Eric Whitman, Martin Wermke, Evidio Domingo-Musibay, Theresa Medina, Sajeve Thomas, Wen Shi, Xiao Wu, Jason A Chesney, Giri Sulur, Friedrich Graf Finckenstein

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma

    Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma oleh Judith D Goldberg, Joseph Markowitz, Jeffrey Weber, Ragini Kudchadkar, Tomas Kirchhoff, Anna Pavlick, Zeynep Eroglu, Melinda Vassallo, David M Woods, Andrew S Brohl, Nikhil I Khushalani, Alison Richards, Younchul Kim, Biwei Cao, Robert Ferguson, Kelsey R Monson, Carol M Amato, Paulo Burke, Ann Strange, Emily Monk, Geoffrey Thomas Gibney

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study

    Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint... oleh Jessica C Hassel, James Larkin, Madan Jagasia, Harriet Kluger, Omid Hamid, Jeffrey Weber, Jason Chesney, Amod Sarnaik, John M Kirkwood, Eric Whitman, Martin Wermke, Evidio Domingo-Musibay, Theresa Medina, Sajeve Thomas, Wen Shi, Karl D Lewis, Nikhil I Khushalani, Parameswaran Hari, Marlana Orloff, Mike Cusnir, Giao Q Phan, Andrew J S Furness, Michael E Egger, Friedrich Graf Finckenstein, Giri Sulur

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival

    Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival oleh James Larkin, Jeffrey Weber, Victoria Atkinson, Michael Millward, Ivan Marquez-Rodas, Luis de la Cruz-Merino, Helen Gogas, Paolo A Ascierto, Anna Maria Di Giacomo, Veerle de Pril, Vanna Chiarion-Sileni, Stephane Dalle, Leslie Fecher, Ana Arance, Jean-Jacques Grob, Nikhil I Khushalani, Michele Del Vecchio, Mario Mandala, C Lance Cowey, Michael Schenker, Petr Arenberger, Maurice Lobo

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: